The latest price and purchasing channels for intravenous human immune globulin (Yimmugo) in 2025

Intravenous human immunoglobulin (Yimmugo) has an increasing global demand as an important drug for the treatment of primary humoral immunodeficiency (PI). Although Yimmugo has not yet been officially launched in the Chinese market, its price and purchase channels abroad have attracted widespread attention.

In the international market,Yimmugo’s price is relatively high. According to reports, Yimmugo is sold overseas for more than US$9,000 per vial, and the specific price may vary depending on the country, drug supplier, and purchase channel. This high price is closely related to factors such as the complex production process, scarcity of raw materials, and market demand. Considering the therapeutic effect of Yimmugo, despite its high price, many patients still choose to purchase it to obtain necessary treatment.

For patients who wish to obtainYimmugo, overseas purchase channels mainly include international drug retailers and online pharmacies. However, since cross-border drug purchases are involved, patients need to be extra cautious when choosing purchasing channels to ensure the authenticity and reliability of the drugs they purchase. In addition, when making international purchases, patients also need to understand the drug import policies of the destination country to ensure compliance with relevant laws and regulations.

It is worth noting thatThe use of Yimmugo is not suitable for all patients, especially those with renal dysfunction or risk of thrombosis, and sufficient evaluation and consultation should be conducted before use. At the same time, since Yimmugo may have certain side effects, it needs to be used under the guidance of a professional doctor.

In China, althoughYimmugo has not yet been approved for marketing, the market demand for such drugs is gradually growing as awareness of immunodeficiency diseases increases. In the future, the drug's launch in China, its price, and medical insurance will attract widespread attention from the pharmaceutical industry and patients.

Reference materials:https://www.drugs.com/history/yimmugo.html